Ubrelvy Untitled Letter – A Double Fault for AbbVie? Or Makeup Misread for FDA?
On August 29, 2024, the U.S. Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) issued an untitled letter to AbbVie, Inc. (AbbVie) regarding a promotional, direct-to-consumer (DTC) television advertisement… more